Article Text
Abstract
Ethical concerns about therapeutic misconception have been raised since the early 1980s. This concept was originally described as research participants' assumptions that decisions relating to research interventions are made on the basis of their individual therapeutic needs. The term has since been used to refer to a range of ‘misunderstandings’ that research participants may have. In this paper, we describe a new concept—therapeutic appropriation. Therapeutic appropriation occurs when patients, or clinicians, actively reframe research participation as an opportunity to enhance patients' clinical care, while simultaneously acknowledging the generalised research aims. To illustrate the concept of therapeutic appropriation, we draw on data from an interview study which we conducted to investigate the experiences of patients and general practitioners involved in clinical trials in primary care. We argue that therapeutic appropriation has two key elements: comprehension that the research project is not necessarily aiming to benefit participants and the deliberate use of incidental features of the research for personal therapeutic benefit of various kinds. We conclude that therapeutic appropriation is a useful concept that refines understanding of potential ethical problems in clinical research, and points to strategies to address them.
- Clinical Ethics
- Primary Care
- Research Ethics
- Informed Consent
Statistics from Altmetric.com
Footnotes
Contributors RM, LG and MG conducted the interviews. All authors were involved in analysis of the data and the drafting of the paper.
Funding University of Melbourne (Research Collaboration Grant).
Competing interests None declared.
Ethics approval University of Melbourne Research Ethics Committee.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Phase 1 oncology trials and informed consent
- Living with Crohn’s disease: an exploratory cross-sectional qualitative study into decision-making and expectations in relation to autologous haematopoietic stem cell treatment (the DECIDES study)
- Two concepts of therapeutic optimism
- Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis
- Beyond informed consent: the therapeutic misconception and trust
- Unrealistic optimism and the ethics of phase I cancer research
- Phase I oncology trials: why the therapeutic misconception will not go away
- Voluntariness of consent in paediatric HIV clinical trials: a mixed-methods, cross-sectional study of participants in the CHAPAS-4 and ODYSSEY trials in Uganda
- Informed consent for early-phase clinical trials: therapeutic misestimation, unrealistic optimism and appreciation
- Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception?